ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,056, issued on March 31, was assigned to CITY OF HOPE (Duarte, Calif.).
"IGF2BP2 inhibitors and uses thereof" was invented by Jianjun Chen (Temple City, Calif.), Hengyou Weng (Duarte, Calif.), Huilin Huang (Duarte, Calif.), David Horne (Altadena, Calif.), Yuelong Ma (Glendora, Calif.), Hongzhi Li (Diamond Bar, Calif.) and Xiaolan Deng (Temple City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein, inter alia, are IGF2BP2 inhibitor compounds and methods of using the same."
The patent was filed on Jan. 27, 2021, under Application No. 17/794,922.
*For further information, including images, charts and tables, please visit: http:...